This page is access-protected. Please enter the passphrase shared with you.
Note: this is a light access screen, not strong security. Anyone with the passphrase — or the page source — can view this content. Confidential materials are shared separately through a controlled data room.
Don't have a passphrase? Email investors@neuronose.io.
NeuroNose is raising a seed round to fund 24 months of operation — through Series A readiness — and to unlock a blend of non-dilutive grant capital.
Through Series A readiness — 100+ paying Phase 1 customers, sensor prototype complete, and the Business Finland R&D and EIC Accelerator doors open.
Paid-in equity in the Finnish entity qualifies NeuroNose for the €100K Business Finland Sprint grant — meaningfully extending the runway non-dilutively.
A deliberate fit for an Epic Angels seed — enough to reach the next milestones, structured as a clean SAFE.
The full Epic Angels seed presentation (PDF).
A one-page overview of the company, the round, and the use of funds.
Detailed financials, scientific references, and corporate documents — shared individually.
Document links above are placeholders. Connect them to your controlled data room (for example DocSend or a Notion workspace with access logging) so that downloads are tracked and access can be revoked. The passphrase gate on this page is convenience, not security.